DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations

Por Nozaki, Koichiro, Kagamu, Hiroshi, Shoji, Satoshi, Igarashi, Natsue, Ohtsubo, Aya, Okajima, Masaaki, Miura, Satoru, Watanabe, Satoshi, Yoshizawa, Hirohisa, Narita, Ichiei
Publicado em 2014

Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens

Por Kubota, Kaoru, Saito, Mitsue, Aogi, Kenjiro, Sekine, Ikuo, Yoshizawa, Hirohisa, Yanagita, Yasuhiro, Sakai, Hiroshi, Inoue, Kenichi, Kitagawa, Chiyoe, Ogura, Takashi
Publicado no Support Care Cancer (2016)

Henoch Schönlein purpura associated with pulmonary adenocarcinoma

Por Mifune, Daiki, Watanabe, Satoshi, Kondo, Rie, Wada, Yoko, Moriyama, Hiroshi, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Tetsuka, Takafumi, Matsuyama, Asako, Ito, Kaoru, Narita, Ichiei
Publicado em 2011

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analys...

Por Baba Junko, Koshio Jun, Ichikawa Kosuke, Kagamu Hiroshi, Tanaka Hiroshi, Kondo Rie, Ota Takeshi, Tanaka Junta, Watanabe Satoshi, Miyabayashi Takao, Narita Ichiei, Yoshizawa Hirohisa
Publicado em 2011-01-01

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analys...

Por Watanabe, Satoshi, Tanaka, Junta, Ota, Takeshi, Kondo, Rie, Tanaka, Hiroshi, Kagamu, Hiroshi, Ichikawa, Kosuke, Koshio, Jun, Baba, Junko, Miyabayashi, Takao, Narita, Ichiei, Yoshizawa, Hirohisa
Publicado em 2011

Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q

Por Watanabe, Satoshi, Minegishi, Yuji, Yoshizawa, Hirohisa, Maemondo, Makoto, Inoue, Akira, Sugawara, Shunichi, Isobe, Hiroshi, Harada, Masao, Ishii, Yoshiki, Gemma, Akihiko, Hagiwara, Koichi, Kobayashi, Kunihiko
Publicado em 2014

mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF

Por Ishikawa, Daisuke, Takeuchi, Shinji, Nakagawa, Takayuki, Sano, Takako, Nakade, Junya, Nanjo, Shigeki, Yamada, Tadaaki, Ebi, Hiromichi, Zhao, Lu, Yasumoto, Kazuo, Nakamura, Takahiro, Matsumoto, Kunio, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Yano, Seiji
Publicado em 2013

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

Por Sato, Ko, Watanabe, Satoshi, Ohtsubo, Aya, Shoji, Satoshi, Ishikawa, Daisuke, Tanaka, Tomohiro, Nozaki, Koichiro, Kondo, Rie, Okajima, Masaaki, Miura, Satoru, Tanaka, Junta, Sakagami, Takuro, Koya, Toshiyuki, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Narita, Ichiei
Publicado no BMC Cancer (2016)

Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial

Por Oizumi, Satoshi, Kobayashi, Kunihiko, Inoue, Akira, Maemondo, Makoto, Sugawara, Shunichi, Yoshizawa, Hirohisa, Isobe, Hiroshi, Harada, Masao, Kinoshita, Ichiro, Okinaga, Shoji, Kato, Terufumi, Harada, Toshiyuki, Gemma, Akihiko, Saijo, Yasuo, Yokomizo, Yuki, Morita, Satoshi, Hagiwara, Koichi, Nukiwa, Toshihiro
Publicado em 2012